drugset / Trial / NCT00348725
Acceptability of a Fixed Combination of Fenofibrate and Metformin
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The primary objective was to assess the acceptability of a 4-week treatment of 4 new fixed-dose combinations of fenofibrate and metformin, in patients with type 2 diabetes and dyslipidemia.
Timeline
- Start
- 2005-04
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fenofibrate | Small molecule | — | — |
| Subject | Metformin | Small molecule | — | — |